中国药业2024,Vol.33Issue(10) :97-100.DOI:10.3969/j.issn.1006-4931.2024.10.020

黄芪复方制剂供试品溶液制备方法优化

Optimization of the Preparation for the Test Solution of Huangqi Compound Preparation

冉京燕 谢委 谢雪佳 汪秋兰 熊微 方建国 王文清
中国药业2024,Vol.33Issue(10) :97-100.DOI:10.3969/j.issn.1006-4931.2024.10.020

黄芪复方制剂供试品溶液制备方法优化

Optimization of the Preparation for the Test Solution of Huangqi Compound Preparation

冉京燕 1谢委 1谢雪佳 1汪秋兰 1熊微 1方建国 1王文清1
扫码查看

作者信息

  • 1. 华中科技大学同济医学院附属同济医院,湖北 武汉 430030
  • 折叠

摘要

目的 优化黄芪复方制剂供试品溶液的制备方法.方法 以提取溶剂为影响因素,以扶正强筋片样品中黄芪甲苷含量为考察指标,优选供试品溶液制备方法.并以此方法对 4 种市售黄芪复方制剂(前列通片、复方石韦片、芪明颗粒、复方血栓通胶囊)进行验证.结果 优选方法为在药典方法基础上,用氨试液-水-水饱和的正丁醇(10∶30∶50,V/V/V)混合溶剂进行加热回流提取(含量测定结果为 1.09mg/g,RSD为 1.93%).4种复方制剂测得黄芪甲苷含量为药典方法的 1.8~2.6倍,RSD介于 1.61%~4.73%.结论 该方法快捷高效,专属性、重复性良好,降低了系统误差,结果准确,可用于黄芪复方制剂供试品溶液的制备.

Abstract

Objective To optimize the preparation method of the test solution of Huangqi Compound Preparation.Methods The preparation method of the test solution was optimized with the extraction solvent as the influencing factor and the content of astragaloside Ⅳ in the Fuzheng Qiangjin Tablets as the investigation indicator.The above optimal method was verified with four commercial Huangqi Compound Preparations(Qianlietong Tablets,Compound Shiwei Tablets,Qiming Granules,Compound Xueshuantong Capsules)as the test subjects.Results The optimal method was that the ammonia test solution-water-water saturated n-butanol(10∶30∶50,V/V/V)was used for heating reflux extraction based on the method of Chinese Pharmacopoeia;the content of astragaloside Ⅳ determined by the above method was 1.09 mg/g with an RSD of 1.93%.The content of astragaloside Ⅳ in four compound preparations determined by the above optimal method was in the range of 1.8 to 2.6 times higher than that determined by the method of Chinese Pharmacopoeia,with an RSD in the range of 1.61%to 4.73%.Conclusion This method is fast,efficient,specific,repeatable,accurate and has low systematical error,which can be used for the preparation of the test solution of Huangqi Compound Preparation.

关键词

黄芪/复方制剂/黄芪甲苷/供试品溶液/高效液相色谱法/含量测定

Key words

Astragali Radix/compound preparation/astragaloside Ⅳ/test solution/HPLC/content determination

引用本文复制引用

出版年

2024
中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
参考文献量16
段落导航相关论文